These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26792597)

  • 41. Prevalence of thyroid abnormalities in patients with rheumatoid arthritis.
    Caron P; Lassoued S; Dromer C; Oksman F; Fournie A
    Thyroidology; 1992 Dec; 4(3):99-102. PubMed ID: 1285039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.
    Ellingsen T; Buus A; Stengaard-Pedersen K
    J Rheumatol; 2001 Jan; 28(1):41-6. PubMed ID: 11196541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects.
    Garduño-Garcia Jde J; Alvirde-Garcia U; López-Carrasco G; Padilla Mendoza ME; Mehta R; Arellano-Campos O; Choza R; Sauque L; Garay-Sevilla ME; Malacara JM; Gomez-Perez FJ; Aguilar-Salinas CA
    Eur J Endocrinol; 2010 Aug; 163(2):273-8. PubMed ID: 20516204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
    del Val del Amo N; Ibanez Bosch R; Fito Manteca C; Gutierrez Polo R; Loza Cortina E
    Clin Exp Rheumatol; 2006; 24(3):281-6. PubMed ID: 16870095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk.
    Raterman HG; van Halm VP; Voskuyl AE; Simsek S; Dijkmans BA; Nurmohamed MT
    Ann Rheum Dis; 2008 Feb; 67(2):229-32. PubMed ID: 17557891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.
    Keenan RT; Swearingen CJ; Yazici Y
    Clin Exp Rheumatol; 2008; 26(5):814-9. PubMed ID: 19032813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Wolfe F
    J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis.
    Ertenli I; Kiraz S; Arici M; Haznedaroglu IC; Calgüneri M; Celik I; Kirazli S
    J Rheumatol; 1998 Jun; 25(6):1054-8. PubMed ID: 9632062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Look beyond the disease activity score of 28 joints (DAS28): tender points influence the DAS28 in patients with rheumatoid arthritis.
    Ton E; Bakker MF; Verstappen SM; Ter Borg EJ; van Albada-Kuipers IA; Schenk Y; van der Veen MJ; Bijlsma JW; Jacobs JW;
    J Rheumatol; 2012 Jan; 39(1):22-7. PubMed ID: 22002014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of thyroid disease in patients with obstructive sleep apnea.
    Bahammam SA; Sharif MM; Jammah AA; Bahammam AS
    Respir Med; 2011 Nov; 105(11):1755-60. PubMed ID: 21820299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis.
    Chandrashekara S; Mukhtar Ahmad M; Renuka P; Anupama KR; Renuka K
    Int J Rheum Dis; 2017 Oct; 20(10):1457-1467. PubMed ID: 28952205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temporomandibular joint problems and periodontal condition in rheumatoid arthritis patients in relation to their rheumatologic status.
    Garib BT; Qaradaxi SS
    J Oral Maxillofac Surg; 2011 Dec; 69(12):2971-8. PubMed ID: 21764200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis.
    Radovits BJ; Fransen J; van Riel PL; Laan RF
    Ann Rheum Dis; 2008 Aug; 67(8):1127-31. PubMed ID: 17965425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum GDF-15 level in rheumatoid arthritis: relationship with disease activity and subclinical atherosclerosis.
    Tanrıkulu O; Sarıyıldız MA; Batmaz İ; Yazmalar L; Polat N; Kaplan İ; Çevik R
    Acta Reumatol Port; 2017; 42(1):66-72. PubMed ID: 27679935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HLA-DRB1 shared epitope alleles in patients with rheumatoid arthritis: relation to autoantibodies and disease severity in a south Indian population.
    Konda Mohan V; Ganesan N; Gopalakrishnan R; Venkatesan V
    Int J Rheum Dis; 2017 Oct; 20(10):1492-1498. PubMed ID: 27943654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Periodontal disease in Thai patients with rheumatoid arthritis.
    Khantisopon N; Louthrenoo W; Kasitanon N; Sivasomboon C; Wangkaew S; Sang-In S; Jotikasthira N; Bandhaya P
    Int J Rheum Dis; 2014 Jun; 17(5):511-8. PubMed ID: 24581320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Study to Evaluate the Thyroid Function in Sero Positive Rheumatoid Arthritis.
    Meena L; Chejara R; Meena PD; Nawal CL; Vedwal A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients.
    Galil SM; El-Shafey AM; Hagrass HA; Fawzy F; Sammak AE
    Int J Rheum Dis; 2016 Apr; 19(4):377-84. PubMed ID: 25292349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.